Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond

Bioanalysis. 2020 Sep;12(17):1199-1203. doi: 10.4155/bio-2020-0116. Epub 2020 May 26.
No abstract available

Keywords: COVID-19; neutralizing antibodies; serology; viral load.

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / analysis*
  • Betacoronavirus / chemistry
  • Biomarkers / analysis
  • COVID-19
  • COVID-19 Vaccines
  • Clinical Trials as Topic
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / therapy*
  • Humans
  • Pandemics
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2
  • Viral Load
  • Viral Vaccines / analysis*

Substances

  • Antiviral Agents
  • Biomarkers
  • COVID-19 Vaccines
  • Viral Vaccines